ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development
Viroclinics-DDL, a Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, a bioinformatics software engineering company, have received approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application. This R&D partnership project combines ‘wet-lab’ (in vitro) diagnostic and high-throughput sequencing expertise of Viroclinics-DDL and ‘dry-lab’ (in silico) bioinformatics and immunomics knowledge of ENPICOM.
Together, the two companies aim to develop an integrated wet and dry lab BCR repertoire sequencing technology that can be offered as a unique full-service proposition. BCR receptor identification and quantification can be used for patients monitoring, evaluation of vaccine efficacy, and, of particular importance in these turbulent times, to improve antibody-based therapeutic development.
“Viroclinics-DDL’s proven ability to perform molecular diagnostic testing at scale provides a tremendous engine to power innovative therapeutics,” said Jos Lunenberg, co-founder and CEO at ENPICOM. “The joint strengths and capabilities of our experienced and welldiversified teams create not only a more complete portfolio of services for our clients; we are confident that our IGX Platform TCR/ BCR sequencing analysis and management, combined with Viroclinics-DDL’s diversified portfolio of assay tools, will allow us to expedite discovery and development of new revolutionary therapeutics and vaccines.”
The collaboration between Viroclinics-DDL and ENPICOM was initiated in May 2019 to jointly deliver TCR repertoire sequencing and analysis service to organizations studying immune system related diseases or developing drugs influencing this system. In January 2021, ENPICOM released an end-to-end software solution for fast and efficient antibody discovery. This new product proposition that aims to address the needs of researchers within the BCR repertoire sequencing field is going to be an important step to facilitate the full-service proposition jointly offered with Viroclinics-DDL.
